Ondansetron HCI API, Bulk, Manufacturer: Cadila Pharmaceuticals, Ltd., Ankleshwar, Gujarat, India 393002
Published December 7, 2016 · Recall initiated: September 9, 2016
Summary
FDA records drug Class II recall D-0164-2017, published December 7, 2016 and initiated September 9, 2016. Recalling firm: Cadila Pharmaceuticals Limited; Status: Terminated; Reported quantity: 6.0kg; Lot: Supplied Batch, 150N004; Exp. 08/20 Supplied Batch, 150N006; Exp. 09/20. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Microbial Contamination of Non-Sterile Product
What to do
Voluntary: Firm initiated · E-Mail
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Cadila Pharmaceuticals Limited
- Distributor
- According to the firm, the API distributed to two consignees in the US. See Consignee list below. Consignee List: 1). LLC LENS Phanna. Russia 2). Claris irljectable, Ahmedabad 3). CPL. Inc, USA
- Lot
- Supplied Batch, 150N004; Exp. 08/20 Supplied Batch, 150N006; Exp. 09/20
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- India
Related recalls
- FDAPhenazopyridine Hydrochloride Tablets, USP, 200 mg, 100 count bottles, Rx only, Manufactured for: BurelDecember 7, 2016
- FDASalsalate Tablets, USP, 500 mg, packaged in a) 500 count bottles (NDC 42937-703-18); b) 100 count bottles (NDCDecember 7, 2016
- FDAPhenazopyridine Hydrochloride Tablets, USP, 100 mg, 100 count bottles, Rx only, Manufactured for: BurelDecember 7, 2016
- FDAPhenazopyridine Hydrochloride Tablets, USP, 100 mg, 100 count bottles, Rx only, Manufactured for: NationwideDecember 7, 2016
- FDAIndiomin MB URINARY ANTISEPTIC, ANTISPASMODIC Capsules, Each capsule contains: Methenamine 120 mg, MonobasicDecember 7, 2016
- FDAPhenazopyridine Hydrochloride Tablets, USP, 200 mg, 100 count bottles, Rx only, Manufactured for: NationwideDecember 7, 2016
Questions about this recall
Was Ondansetron HCI API, Bulk, Manufacturer: Cadila Pharmaceuticals, Ltd., Ankleshwar, Gujarat, India 393002 recalled?
Yes. FDA published recall D-0164-2017 on December 7, 2016. Reported hazard: Microbial Contamination of Non-Sterile Product
What should I do if I have this product?
Voluntary: Firm initiated · E-Mail